Acupuncture for Urinary Issues in Prostate Cancer Survivors

Recruiting in Palo Alto (17 mi)

+7 other locations

Overseen byKevin Liou, MD

Age: 18+

Sex: Male

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase 1 & 2

Waitlist Available

Sponsor: Memorial Sloan Kettering Cancer Center

No Placebo Group

Approved in 4 Jurisdictions

Trial Summary

What is the purpose of this trial?

The purpose of this study is to test whether acupuncture can improve nocturia in prostate cancer survivors. This is the first time acupuncture is being studied for nocturia in prostate cancer survivors. Researchers will see if acupuncture is a practical treatment option for prostate cancer survivors with nocturia. The study will also look at the effect acupuncture has on nocturia and other symptoms prostate cancer survivors experience such as insomnia, hot flashes, anxiety, depression, tiredness (fatigue), sexual dysfunction, and cognitive (mental) difficulties.

Eligibility Criteria

This trial is for prostate cancer survivors over 18 with no current evidence of cancer, experiencing frequent nighttime urination (nocturia). They must not have started new urinary medications or changed doses in the last month and can't have untreated sleep disorders, psychiatric conditions, or be at high risk for obstructive sleep apnea.

Inclusion Criteria

I have been diagnosed with prostate cancer before.

I do not have prostate cancer.

I wake up to urinate 2 or more times every night for the last month.

See 1 more

Exclusion Criteria

I have changed my medication for urinary problems in the last month.

I plan to start or change treatments for urinary symptoms during the study.

I am unable to give consent by myself.

See 7 more

Treatment Details

Interventions

Acupuncture (Behavioural Intervention)

Trial OverviewThe study tests if acupuncture can help reduce nocturia in prostate cancer survivors. It's a first-of-its-kind study to see if this traditional technique could also ease insomnia, hot flashes, anxiety, depression, fatigue, sexual dysfunction and cognitive issues related to prostate cancer survivorship.

Participant Groups

2Treatment groups

Experimental Treatment

Group I: Waitlist ControlExperimental Treatment2 Interventions

The waitlist control group will not receive any acupuncture treatments during the 14-week waiting period. Patients in waitlist control group will have the option to receive up to 10 acupuncture treatments after a 14-week waiting period.

Group II: AcupunctureExperimental Treatment2 Interventions

Acupuncture group will receive 10 treatments of acupuncture over the course of 10 weeks (i.e. one treatment a week) with a +/- 14-day window.

Acupuncture is already approved in United States, European Union, China, Australia for the following indications:

🇺🇸 Approved in United States as Acupuncture for: